HT-29 nuclear extract


  • Specification
  • Related Products
Cat.No.:  EL-0389
Product Name:  HT-29 nuclear extract
Description:  HT-29 nuclear extract was prepared from a cell culture of the human colorectal adenocarcinoma HT-29 cell line. The HT-29 cell line was originally derived from intestinal tumor tissue obtained from a 44 year old Caucasian female patient with colorectal adenocarcinoma. HT-29 cells are morphologically epithelial, are CD4 negative, and produce carcinoembryonic antigen (CEA) and immunoglobulin A (IgA). This cell line contains a mutation in codon 273 of the p53 gene that results in an Arg>His substitution. In the absence of carbohydrates, HT-29 cells differentiate into polarized epithelium and, therefore, have been used as in vitro model systems to study epithelial differentiation. However, the HT-29 cell line is most commonly used in research as a model for colorectal cancer in studies related to growth and tumorigenicity.
Species:  Human
Source:  Human epithelial colon; colorectal adenocarcinoma
Components:  200 µg of HT-29 nuclear extract at 5.6 µg/µl.
Extract Composition:  HT-29 nuclear extract is supplied in Dilution Buffer (20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM PMSF and 0.5 mM DTT).
Application Notes:  HT-29 nuclear extract is recommended for use in studies related to colorectal cancer and epithelial differentiation.
Storage:  Store at -80°C. Aliquot to avoid repeated freezing and thawing.
Warning:  For research use only, not for diagnostic or therapeutic use.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.